Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703
Crossref DOI link: https://doi.org/10.1007/s00280-015-2789-5
Published Online: 2015-06-03
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kudo, Kenichiro
Hotta, Katsuyuki
Ichihara, Eiki
Yoshioka, Hiroshige
Kunimasa, Kei
Tsubouchi, Kazuya
Iwasaku, Masahiro
Kato, Yuka
Oze, Isao
Takigawa, Nagio
Tanimoto, Mitsune
Kiura, Katsuyuki
Text and Data Mining valid from 2015-06-03